Tabla de contenido
Referencias:
"FDA Public Health Notification: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
1
Bloodborne Pathogens: Initial Communication" (2010) http://www.fda.gov/MedicalDevices/Safety/
AlertsandNotices/ucm224025.htm
"CDC Clinical Reminder: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
2
Bloodborne Pathogens" (2010) http://www.cdc.gov/injectionsafety/Fingerstick-DevicesBGM.html
American Diabetes Association. (2015). 2. Classification and Diagnosis of Diabetes. Diabetes Care,
3
38(Supplement 1), S8-S16.
Atkins SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S: Fingerstick glucose determination in shock. Ann Int
4
Med 114: 1020-1024. 1991.
Sandler M, Low-Beer T: Misleading capillary glucose measurements. Practical Diabetes 7: 210. 1990.
5
Wickham NWR, Achar KN, Cove DH: Unreliability of capillary blood glucose in peripheral vascular disease.
6
Practical Diabetes 3: 100. 1986.
Diabetes Care. January 2010, vol. 33, no. Supplement 1, S11-S61.
7
Hirsch, I. (2005). Glycemic Variability: It's Not Just About A1C Anymore! Diabetes Technology and Therapeutics,
8
7 (5), 780-783.
Mayo Clinic Proceedings February 2007, vol. 82, no. 2, 229-236.
9
Pearson J, Bergenstal R. Fine-Tuning Control: Pattern Management Versus Supplementation: View 1: Pattern
10
Management: an Essential Component of Effective Insulin Management. Diabetes Spectr. April 1, 2001;14(2)
75-78.
54
Tabla de contenido
